Invention Publication
- Patent Title: COMPOSITIONS AND METHODS FOR TARGETED ANTIFIBROTIC THERAPY IN CHRONIC PANCREATITIS
-
Application No.: US18276111Application Date: 2022-02-04
-
Publication No.: US20240115729A1Publication Date: 2024-04-11
- Inventor: Kimberly A. Kelly, Ph.D. , Jessica Hung
- Applicant: University of Virginia Patent Foundation
- Applicant Address: US VA Charlottesville
- Assignee: University of Virginia Patent Foundation
- Current Assignee: University of Virginia Patent Foundation
- Current Assignee Address: US VA Charlottesville
- International Application: PCT/US2022/015272 2022.02.04
- Date entered country: 2023-08-07
- Main IPC: A61K47/69
- IPC: A61K47/69 ; A61K31/352 ; A61K45/06 ; A61K47/58 ; A61P5/00 ; C07K7/06

Abstract:
Provided are compositions that include targeting peptides and methods for using the same to treat and/or prevent various diseases, disorders, and/or conditions. In some embodiments, the compositions and methods relate to liposomal compositions that include a liposome, the surface of which is conjugated to a peptide having an amino acid sequence as set forth in any of SEQ ID NOS: 3-38, optionally wherein the liposome encapsulates a therapeutic agent or a detectable agent. In some embodiments, the peptide has an amino acid sequence that is one of SEQ ID NOs: 14, 19, 20, 27, and 28. Also provided are methods treating or preventing fibrosis, for decreasing the incidence of a disease, disorder, or condition associated with chronic pancreatitis (CP), for targeting active agents to targets, including but not limited to collagen III-expressing cells and extracellular matrix, and for decreasing incidence of side effects associated with apigenin treatment.
Information query